
zzso zzso zzso was administered to patients with advanced stages of cancer in a phase I drug toxicity zzso zzso was given zzso twice daily at zzso intervals over a zzso course of therapy in zzso ranging from zzso to 100 X zzso zzso A total of 28 patients was zzso including 9 with breast zzso 11 with other solid tumors, and 8 with zzso zzso zzso cell parameters were determined for each patient before, zzso and up to 20 days after zzso zzso was evident after 1-2 days of zzso administration, became zzso after zzso days of therapy, and then returned to baseline values by day 13 zzso zzso natural killer zzso cell activity was found to increase significantly by 2 h after the initial zzso injection, especially in patients receiving the higher zzso However, most subjects demonstrated a return to baseline zzso levels at 24 h despite the continued presence of elevated serum zzso of zzso By day 7 of therapy, zzso function was markedly zzso Following zzso of zzso zzso levels rapidly returned to zzso baseline zzso Changes in zzso zzso function zzso tended to parallel those of zzso zzso Although zzso function was affected by zzso therapy, no change in the percentage of circulating zzso zzso cells was zzso This indicates that the zzso cells were probably present in the zzso but were not able to express their zzso zzso 

